High-level SNHG5 expression may provide a cytoplasmic trap for MTA2 because SNHG5 can directly bind MTA2 to prevent its transfer from the cytoplasm into the nucleus, thus inhibiting the MTA2 functions in GC cell growth and metastasis [129]. The gene discussed is SNHG5; the disease is gastric cancer.